The SHIELD Whole Lung Lavage Study (SHIELD)
Silicosis - Harnessing New Ideas to Conquer the Re-emergence of an Ancient Lung Disease: The SHIELD Whole Lung Lavage Study
Sponsor: The University of Queensland
A observational or N/A phase clinical study on Silicosis, this trial is ongoing. The trial is conducted by The University of Queensland and has accumulated 4 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Jan 2025 — Present [monthly]
Unknown
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Jul 2022 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Jun 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Queensland
For direct contact, visit the study record on ClinicalTrials.gov .